MAXAMOX amoxicillin trihydrate 500mg/5mLpowder for oral suspension bottle

Страна: Австралія

мова: англійська

Джерело: Department of Health (Therapeutic Goods Administration)

Активний інгредієнт:

amoxicillin trihydrate, Quantity: 114.82 mg/mL (Equivalent: amoxicillin, Qty 100 mg/mL)

Доступна з:

Sandoz Pty Ltd

Фармацевтична форма:

Oral Liquid, powder for

Склад:

Excipient Ingredients: silicon dioxide; sodium citrate; purified talc; aspartame; sodium benzoate; citric acid; Guar Gum; Flavour

Адміністрація маршрут:

Oral

Одиниць в упаковці:

60mL, 100mL

Тип рецепту:

(S4) Prescription Only Medicine

Терапевтичні свідчення:

Treatment of the following infections due to susceptible strains of sensitive organisms: Note: Therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. Amoxycillin alone or in combination with another antibiotic, may be used in an emergency where the causative organism has not been identified. Respiratory tract infections (acute and chronic) including acute otitis media (AOM): H. influenzae; Streptococcus; S. pneumoniae; Staphylococcus, nonpenicillinase producing; E. coli (see Microbiology). Urogenital infections (complicated and uncomplicated, acute and chronic): E. coli (see Microbiology), P. mirabilis and Strep. faecalis. Gonorrhoea: N. gonorrhoeae (nonpenicillinase producing). Skin and skin structure infections: Staphlococcus, nonpenicillinase producing; Streptococcus, E. coli (see Microbiology). Prophlaxis of endocarditis: Amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis. Infections caused by pathogens with established penicillin G susceptibility should preferentially be treated with penicillin G.

Огляд продуктів:

Visual Identification: White to slightly yellowish powder.; Container Type: Bottle; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Статус Авторизація:

Registered

Дата Авторизація:

2003-07-22

інформаційний буклет

MAXAMOX
®
1
MAXAMOX
®
_Amoxicillin Trihydrate suspension _
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS
LEAFLET
This leaflet answers some common
questions about Maxamox
Suspension.
It does not contain all the available
information. It does not take the
place of talking to your doctor or
pharmacist.
All medicines have risks and
benefits. Your doctor has weighed
the risks of you taking Maxamox
Suspension against the benefits they
expect it will have for you.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING THIS MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT MAXAMOX
SUSPENSION IS
USED FOR
The name of your medicine is
Maxamox Suspension. It contains the
active ingredient amoxicillin
trihydrate.
Maxamox Suspension is an antibiotic
used to treat infections in different
parts of the body caused by bacteria.
Maxamox Suspension belongs to a
group of antibiotics called
penicillins. These antibiotics work by
killing the bacteria that are causing
your infection.
This medicine can also be used to
prevent certain infections.
Maxamox Suspension will not work
against infections caused by viruses
such as colds or the flu.
Your doctor may have prescribed
Maxamox Suspension for another
reason. Ask your doctor if you have
any questions about why Maxamox
Suspension has been prescribed for
you.
Maxamox Suspension is available
only with a doctor's prescription.
Maxamox Suspension is not
addictive.
BEFORE YOU TAKE
MAXAMOX
SUSPENSION
_WHEN YOU MUST NOT TAKE IT _
DO NOT TAKE MAXAMOX SUSPENSION
IF:
•
YOU HAVE AN ALLERGY TO
AMOXICILLIN, ANY OTHER
PENICILLINS OR ANY OF THE
INGREDIENTS LISTED AT THE END OF
THIS LEAFLET
•
YOU HAVE HAD A SERIOUS ALLERGIC
REACTION TO ANY Β-LACTAM
ANTIBIOTICS (E.G. PENICILLINS,
CEPHALOSPORINS, CARBAPENEM OR
MONOBACTAM). THESE ARE
ANOTHER GROUP OF ANTIBIOTICS
SIMILAR TO PENICILLINS.
Some of the symptoms of an
allergic reaction may include
asthma, wheezing, shortness of
breath, swelling of the face, lips
or tongue which may cause
difficulty in swallowi

Характеристики продукта

_Product Information _
_Maxamox 500mg/5mL Powder for Oral Suspension _
_01/2018 Page 1 _
_ _
_Sandoz Pty Ltd _
_ _
_Version 05 _
PRODUCT INFORMATION
MAXAMOX
®
_ _
500MG/5ML POWDER FOR ORAL SUSPENSION
NAME OF THE MEDICINE
Active Ingredient:
Amoxicillin trihydrate
Inactive Ingredients:
Anhydrous citric acid, sodium benzoate, aspartame, purified talc,
sodium
citrate anhydrous, guar gum, silicon dioxide, lemon flavouring, peach-
apricot flavouring and orange flavouring.
DESCRIPTION
Amoxicillin trihydrate is a white or almost white, crystalline powder.
It is slightly soluble in water
and in ethanol (96%); practically insoluble in chloroform, in ether
and in fatty oils.
Structural Formula:
N
S
O
H
H
CH
3
CH
3
O
H
NH
2
H
N
H
O
H
COOH
.
3H
2
O
Chemical Name:
(2
_S_
,5
_R_
,6
_R_
)-6-[(
_R_
)-2-amino-2-(4-hydroxyphenyl)acetamido]-3,3-dimethyl-
7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate.
Molecular Formula:
C
16
H
19
N
3
O
5
S.3H
2
O
Molecular Weight:
419.4
CAS Number:
61336-70-7
PHARMACOLOGY
MICROBIOLOGY
Amoxicillin trihydrate is a broad-spectrum penicillin similar to
ampicillin in its bactericidal action.
It is believed to act through the inhibition of biosynthesis of cell
wall mucopeptide. It is active
against both gram-positive and gram-negative microorganisms.
Amoxicillin is active
_in vitro_
against beta-lactamase negative strains of
_Proteus mirabilis_
, and
_Haemophilus influenza_
.
_In vitro_
studies
have
also
demonstrated
activity
against
most
strains
of
alpha-
and
beta-haemolytic
streptococci,
_Streptococcus pneumoniae_
, and beta-lactamase negative strains of staphylococci,
_Neisseria gonorrhoeae, Neisseria meningitidis and Enterococcus
faecalis_
. However, some of the
organisms are sensitive to amoxicillin only at concentrations achieved
in the urine. Strains of
gonococci which are relatively resistant to benzyl penicillin may also
be resistant to amoxicillin.
Amoxicillin
is
not
effective
against
penicillinase
producing
bacteria,
particularly
resistant
staphylococci which now have a h